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The United Kingdom (UK) has thus far been consid-
ered to be free from tick-borne encephalitis (TBE), 
yet in July 2019, a German infant developed serologi-
cally diagnosed TBE following a tick bite in southern 
England. This first report of a probable human case 
together with recent findings of TBE virus in ticks 
in foci in England suggest that TBE may be acquired 
in parts of England and should be considered in 
patients with aetiologically-unexplained neurological 
manifestations.
End-July 2019, a case of tick-borne encephalitis (TBE) 
in a 3-month-old infant was notified to the German 
mandatory surveillance system for infectious diseases. 
The patient’s family, resident in a TBE-non-endemic 
region in Germany, had holidayed in England during the 
incubation time. We present the case report based on 
German surveillance data, information provided by the 
family, laboratory reports and two hospital discharge 
summaries, and describe the public health response.
Case report
A German family including a 3-month-old infant spent 
their holiday in southern England from 1 to 15 July 2019 
(Figure 1). The mother was not vaccinated against nor 
reported past TBE infection. On 6 July, the family pic-
nicked near Woodgreen in the New Forest National 
Park (Figure 2), where the child laid on a blanket on 
the grass. An unengorged tick, attached to the infant’s 
neck, was discovered on 7 July. The tick was removed 
incompletely, using tweezers, and the wound was dis-
infected. The remaining tick fragments detached 2 
days later.
The previously healthy infant developed fever on 17 
July, 11 days after the tick bite. Medical history was 
unremarkable; the infant had thus far received one 
hexavalent routine childhood vaccination. Subtracting 
the maximum incubation period of 28 days [1] from 
symptom onset, renders 19 June as the earliest pos-
sible infection date. The infant reportedly did not 
visit any other location where a tick bite could have 
occurred except their home area in Hesse, Germany 
which is non-endemic for TBE. Each bout of fever 
was accompanied by focal seizures, lasting ca 1 min. 
Hospitalisation occurred on 17 July, prompting a series 
of diagnostic tests (Table). Based on elevated cerebro-
spinal fluid markers (Table), meningitis was diagnosed 
and the infant was treated with intravenous cefotax-
ime, ampicillin and aciclovir. The focal seizures became 
generalised lasting up to 5 min and were treated with 
anticonvulsants (clonazepam, midazolam, leveti-
racetam). The infant was transferred to a specialised 
hospital on 20 July. Magnetic resonance imaging and 
repeated electroencephalograms revealed pathological 
results (Table). Having excluded numerous neurotropic 
pathogens, TBEV-specific serology tested positive for 
IgM and IgG (Table) and meningoencephalitis because 
of TBEV infection was diagnosed by the treating physi-
cians. The infant was discharged 15 days after admis-
sion with mild remaining neurological symptoms, which 
had subsided by the check-up 6 weeks later.
Public health response
Upon receiving the notification on 25 July, the Robert 
Koch Institute asked the patient’s family for their 
detailed travel history in England. One week later, the 
event was reported through the European Commission 
Early Warning and Response System (EWRS) selective 
exchange to inform United Kingdom (UK) colleagues.
Following TBEV detection in ticks in Thetford Forest in 
2019, from samples collected February 2018 to January 
2019 [2], enhanced clinical surveillance activities were 
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Figure 1
Timeline of infection, disease progression and public health response to the probable tick-borne encephalitis case in an 
infant, Germany, July–August 2019
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Maximum incubation time 19 Jun to 15 Jul
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Symptom onset
Hospitalisation 17 Jul to 01 Aug
06 Jul
Picnic
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Tick bite noticed
Holiday in England 01 to 15 Jul
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Positive TBE test 
Calendar week 2019
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EWRS: Early Warning and Response System; TBE: tick-borne encephalitis.
Figure 2
Map of the likely place of infection of tick-borne encephalitis case in a German infant, Woodgreen, New Forest National 
Park, England, 2019
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TBEV: tick-borne encephalitis virus; UA: unitary authority.
Source: Ordnance Survey and National Statistics data for geographical and administrative boundaries.
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Table
Diagnostic tests performed on the probable case of tick-borne encephalitis (TBE) during hospitalisation, Germany, 
July–August 2019
Date (2019) Test (sample type/assay) Result Interpretation
17–19 Jula CSF diagnostics
1,000 cells (norm: 0–5) 
 
(40% granulocytes, 60% lymphocytes) 
 
1.5 g protein 
 
59 mg/dL glucose level (norm: 40–80)
Inflammation
17–19 Jula Blood culture Negative Normal
17–19 Jula CSF culture Negative Normal
17–19 Jula
Multiplex PCR (CSF) for: 
 
-Escherichia coli, 
 
-Haemophilus influenzae, 
 
-Listeria monocytogenes, 
 
-Neisseria meningitidis, 
 
-Streptococcus, 
 
-Cytomegalovirus, 
 
-Enterovirus, 
 
-Herpes Simplex Virus 1 and 2, 
 
-Human herpesvirus 6, 
 
-Human parechovirus, 
 
-Varicella zoster virus, 
 
-Cryptococcus
Negative Normal
17–19 Jula Enterovirus (stool) Negative Normal
20 Jul MRSA and MRGN screening Negative Normal
23 Jul TBEV-IgG (serum)b 10.3 AE/mL Positive (cut-off: 0.241)
23 Jul TBEV-IgM (serum)b 12.5 index Positive (cut-off: 0.234)
25 Jul Borrelia burgdorferi (IgG-ELISA) < 5.2 U/mL Negative (cut-off: < 7 U/mL)
22 Jul and 25 Jul Electroencephalography
Slowed activity in right hemisphere; 
 
Epileptic activity in right temporal/central and left 
occipital areas.
Pathological
01 Aug Magnetic resonance imaging
Leptomeningeal enhancement. 
 
No sign of parenchymal defect or brain abscess.
Pathological
CSF: cerebrospinal fluid; MDRGN: multidrug resistant Gram-negative bacteria; MRSA: methicillin-resistant Staphylococcus aureus; TBEV: tick-
borne encephalitis virus.
a Performed during the first hospital stay. Exact test dates were not given in discharge summary.
b The test kit used was Enzygnost Anti-TBE virus (IgG, IgM) (Siemens, Marburg, Germany) which determines a specific cut-off for each run 
(alpha-method).
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underway in the east of England, focusing on encepha-
litis cases without confirmed cause [3]. Following the 
EWRS message, these activities were extended to areas 
surrounding the New Forest National Park. TBEV sero-
prevalence studies in groups at high risk of tick bites 
and in the general population are also being imple-
mented in both areas. Tick surveillance was already 
underway around the New Forest National Park follow-
ing previous findings [2], but additional tick surveys 
were conducted around Woodgreen on 8 and 23 August 
2019. Only 135 ticks (70 nymphs, 25 adult males, 40 
adult females) were collected, likely because the peak 
tick questing season had already passed. Pools of 10 
nymphs, five adult males or five adult females were 
homogenised for RNA extraction and RT-PCR analy-
sis [4]. No TBEV or other TBEV-serocomplex RNA was 
detected.
Discussion
We report a human TBE case, believed to be the first 
acquired in the UK. Diagnosis was by serology only, 
which can be regarded as a limitation. No reserve sam-
ple was available for additional testing (TBE-specific 
PCR or neutralization assay [5]). Because of the lack of 
therapeutic consequences, no follow-up blood sample 
was drawn from the infant; therefore it was not pos-
sible to test for a rise in IgG titre in paired samples [5].
Several pieces of evidence support the likelihood that 
this is a true TBE case. First, the tick bite, the clinical 
symptoms and the incubation time of 11 days, close to 
the median of 8 days [5], fit the typical picture of TBEV-
infection. This patient did not have the biphasic course 
of TBE, which is observed in 72–87% of TBE cases [5]. 
Second, as the infant resides in a TBE-non-endemic 
area in Germany it is highly unlikely that a second tick 
bite occurred there within the incubation time, went 
unnoticed and caused the infection. The likelihood of 
the infection having occurred near Woodgreen is far 
higher given the known tick bite. Third, the extensive 
array of differential diagnostics ruled out numerous 
other neurotrophic pathogens. Fourth, the TBE serolog-
ical results were far above the cut-offs. Finally, as the 
mother did not report any past TBE vaccination or infec-
tion, it is unlikely that maternal TBE antibody transfer 
occurred, and certainly not with such high titres.
In 2019, TBEV was reported for the first time in ticks 
in discrete foci in Thetford Forest, England [2], but the 
pathogenicity is unknown and no other human cases 
have yet been identified in the UK. Tick surveys around 
Woodgreen did not detect any TBEV, however, it must 
be noted that only a small tick sample was collected. 
Yet, a pool of questing ticks sampled previously, on the 
Hampshire/Dorset border in June 2019, tested TBEV-
positive, suggesting that TBEV has established itself 
in the UK [6]. Follow-up tick surveys will be conducted 
during spring 2020.
Although the clinical presentation and serology are 
consistent with the European TBE case definition [7], 
this interpretation has to be considered in light of the 
natural endemicity of Louping ill virus (LIV) in the UK. 
Until recently, LIV was believed to be the only virus 
of the TBE-serocomplex endemic in the UK [8]. Like 
TBEV, LIV is also transmitted by  Ixodes ricinus  ticks 
and mainly occurs in sheep, cattle and red grouse in 
upland grazing areas of the British Isles [8]. LIV infects 
humans in rare cases and cross-reacts with TBEV sero-
logically. In the absence of an isolate or sequence data 
from acute phase samples, the exact aetiology in the 
case presented here remains uncertain. However, LIV 
is most prevalent in upland areas, which are located 
mostly in the north and west of the UK, and less than 
50 human clinical LIV cases have been reported since 
1934 [8], with one in England reported as recently as 
2011 [9]. The likelihood of LIV thus is low in our case 
and we believe that it is a true TBEV-infection.
This first probable human TBEV-infection in England 
and the detection of TBEV in ticks stand in accordance 
with the patchy spread of TBEV to new areas observed 
in parts of Europe. In Germany, the number of TBE-
endemic districts increased from 129 in 2007 to 161 
in 2019 [10]. The first TBE cases from the Netherlands 
were reported in 2016 [11,12]; and a new focus was 
recently discovered in Denmark following three human 
TBE cases in summer 2019 [13]. TBEV can spread to 
new areas through mammalian hosts or migratory birds 
infested with TBEV-carrying ticks [14]. This may either 
lead to sporadic infections, or sometimes to the estab-
lishment of new foci, if local climatic conditions are 
favourable to the transmission cycles between ticks 
and their rodent hosts [5].
In England, the public health authorities currently 
assess the risk of TBEV infection as very low for the 
general population and low for those who may be bit-
ten by ticks in areas where infected ticks are located 
[15]. Seroprevalence studies in groups at high risk of 
tick bites and in the general population, tick sampling 
and enhanced surveillance of human encephalitis 
cases without confirmed cause are underway to bet-
ter understand the human infection risk in areas where 
TBEV was detected in ticks or wildlife. Public Health 
England continues to promote tick awareness for those 
spending time outdoors. The public health risks from 
TBEV in England will be dynamically reviewed as new 
findings come to light.
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